<DOC>
	<DOCNO>NCT00401375</DOCNO>
	<brief_summary>To evaluate safety efficacy MNTX patient undergone segmental colectomy ass time end surgery first bowel movement significantly short MNTX regimen equivalent assessment use placebo regimen .</brief_summary>
	<brief_title>Study Intravenous ( IV ) Methylnaltrexone Bromide ( MNTX ) Treatment Post-Operative Ileus ( POI ) .</brief_title>
	<detailed_description />
	<mesh_term>Ileus</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<criteria>Selected Male female patient least 18 year age Patients must meet ASA physical status I , II , III Patient must sign ICF Patients must schedule segmental colectomy Females childbearing potential must negative serum pregnancy test screen visit Negative history chronic active hepatitis B , HCV HIV infection Selected Patients receive investigational new drug previous 30 day Females pregnant lactate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>